How many email patterns does Garuda Therapeutics use?

Garuda Therapeutics uses 3 known email patterns.

What domain does Garuda Therapeutics use for work emails?

Garuda Therapeutics uses garudatx.com for work email addresses.

Most Common Email Formats at Garuda Therapeutics

Garuda Therapeutics's most common email format is First.Last@garudatx.com (ex. John.Doe@garudatx.com), used for 97% of garudatx.com addresses. Garuda Therapeutics uses 3 email patterns.

@garudatx.com

3 patterns

Format	Example	Share of garudatx.com
First.Last@garudatx.comMost common	John.Doe@garudatx.com	97%
First.Middle@garudatx.com	John.Michael@garudatx.com	2%
FLast@garudatx.com	JDoe@garudatx.com	1%

Need a specific person's email?

Browse Garuda Therapeutics's employee directory (about 9 employees) and reveal verified emails free.

Frequently Asked Questions

What does Garuda Therapeutics do?

Garuda Therapeutics was founded in 2021 and operates in the Biotechnology Research industry, alongside similar companies like Repertoire Immune Medicines, Carisma Therapeutics and ACORN. You can visit garudatx.com. Explore Garuda Therapeutics's company overview page for more information.

What is Garuda Therapeutics's email address format?

Garuda Therapeutics's email format typically follows the pattern of First.Last@garudatx.com; this email format is used 97% of the time. Other contacts within LeadIQ's database had email formats such as First.Middle@garudatx.com and FLast@garudatx.com. Looking for more contact data? Unlock accurate emails and phone numbers from millions of profiles verified in real-time.

How many employees does Garuda Therapeutics have currently?

Garuda Therapeutics has approximately 9 employees as of October 2026. Key team members to contact include Senior Executive Assistant To President & Chief Executive Officer: M. M., Senior Quality Assurance Consultant: M. A. and Senior Scientist: Z. L. For more team information and contact data, explore Garuda Therapeutics's employee directory with LeadIQ.

Garuda Therapeutics Email Format

Biotechnology ResearchMassachusetts, United States2-10 Employees

Garuda Therapeutics, based in Cambridge, Massachusetts, is a biotechnology research company focused on stem cell therapy. It is developing off-the-shelf, self-renewing blood stem cells intended to replace donor- or patient-derived cells in hematopoietic stem cell transplants. The goal is to provide rapid, broad access to durable, HLA-compatible, transgene-free therapies that could address more than 120 diseases, similar in potential to bone marrow transplants.

It operates in the biotechnology sector, aiming to deliver scalable, ready-to-use stem cell products for patients and care teams. In March 2025, Garuda Therapeutics named Avanish Vellanki as President and Chief Executive Officer.

Most common format

First.Last@garudatx.com

Example: John.Doe@garudatx.com

3 patterns. See all formats

Verify a Garuda Therapeutics email address

Free with a LeadIQ account. No credit card.

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust LeadIQ to help them build pipeline confidently.

Everything for prospecting,
in one platform.

What you can expect from LeadIQ:

B2B data verified in real-time
Sync data to your CRM, & add it to an outreach sequence in one click
Integrations with your tech stack for optimal efficiency
A patented AI cold email generator
Account & contact-level job change tracking

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

Most Common Email Formats at Garuda Therapeutics

@garudatx.com

Need a specific person's email?

Frequently Asked Questions

What does Garuda Therapeutics do?

What is Garuda Therapeutics's email address format?

How many employees does Garuda Therapeutics have currently?

Garuda Therapeutics Email Format

Ready to create more pipeline?

Everything for prospecting,in one platform.

What you can expect from LeadIQ:

Ready to create more pipeline?

Everything for prospecting,
in one platform.